Clinical Trials Browser

Phase 2 × Neoplasms, Germ Cell and Embryonal × Paclitaxel × Clear all

NCT01873326 2025-07-03

Paclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With Previously Untreated Intermediate- and Poor-risk Germ Cell Tumors

Phase 2 Active not recruiting

Neoplasms, Germ Cell and Embryonal

NCT00864318 2021-01-12

TICE

Phase 2 Completed

Neoplasms, Germ Cell and Embryonal, Recurrence

NCT02414685 2020-08-07

TIP

Phase 2 Completed

Neoplasms, Germ Cell and Embryonal

NCT00183820 2017-07-07

Study of Gemcitabine, Oxaliplatin, and Paclitaxel in Patients With Refractory Germ Cell Carcinoma

Phase 2 Completed

Neoplasms, Germ Cell and Embryonal, Testicular Neoplasms

NCT00611962 2008-02-11

Phase II Study of Oxaliplatine-Paclitaxel in Patients With Metastatic Germ Cell Tumor Refractory to Cisplatin

Phase 2 Completed

Neoplasms, Germ Cell and Embryonal